Who invested in EnClear Therapies

2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$7.0Mraised across 2 rounds since 2019, from 2 sources

$2.0MSeed$5.0MGrant

Latest round: Grant, $5.0MSept 2024
Step-upi: 2.5×
Investors: 5

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201920202021202220232024

$2.0MSeed$5.0MGrant

First round: Seed, $2.0M
Biggest round: $5.0M
Between rounds: 5.5 years

The rounds

Sept 2024
Grant$5.0M1 new1 returning
- Founders Fund
- Presight Capital
Source recorded
Mar 2019
Seed$2.0M4 new
- Presight Capital
- Thiel Capital
- Bioverge Ventures
- Sanford Biosciences
Reported by FinSMEs

Founders and team

From the SEC filings it signed: 1 on the team.

Anthony DePasquaExecutive Officer, Directori

On the board, as filediJason CammJonathan FlemingKasper Roet

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Seed2019Grant2024

Presight Capital

Founders Fund

Thiel Capital

Bioverge VenturesSanford Biosciences

Everyone who backed them

Presight CapitalVC firm2rounds

Founders FundVC firm1round

Thiel CapitalVC firm1round

Bioverge VenturesVC firm1round

Sanford Biosciencesno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 6 firms list EnClear Therapies as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.